![]() |
|
|||
![]() |
|
Local Iron Chelation Therapy Policy Statement for use by PCTs Invitation to This invitation is to GPs, practice nurses, health visitors, head teachers, patients, carers and health care professionals. This is our seventh annual network study day, and patients have told us they found this coming together of a range of different people have helped improve their experience in accessing the care they need in the hospital and in the community. Programme To register please Tel: 020 8795 6748 and leave your name, and address or Email: mary.joyce@brentpct.nhs.uk for a registration form. DOH Stroke Consultation Response
Please read the network's response below:
Sixth Annual Study Day 4th July 2007 9.30am to 1.30pm The NW London haemoglobinopathy network The NW London haemoglobinopathy managed clinical network (MCN) will ensure that the target set in the NHS Newborn Screening Programme is met: “there will be a new national linked antenatal and neonatal screening programme for haemoglobinopathy and sickle cell disease”(NHS Sickle & Thalassaemia screening programme: www.screening.nhs.uk/sickleandthal) To date, SCD & Thalassaemia have been managed exclusively by the acute sector. This has partly been due to the diseases being seen as a specialised condition for which general practitioners may have little knowledge or training. This cycle needs to be broken with clear instructions for parents on when to use primary care and the acute hospital. To achieve this, practical information needs to be given to the general practitioner e.g. dosages of medications, steady state values, and the information that has been given to parents about the condition and ways of accessing hospital care. SCD & Thalassaemia should be considered as chronic illness with acute exacerbations that have far –reaching effects on education, family life, social integration and the emotional well being of the child, adolescent & young people and the family. Community services & patient hand-held records During this year’s annual study day, we shall be looking at how we are remodelling community services across NW London and liaising with the voluntary sector to ensure implementation of the UK care standards for sickle cell in childhood and for thalassaemia, and to evaluate the usefulness of a locally designed measuring tool (i.e. patient hand-held records) in helping provide practical information to GPs, and helping PCTs audit the standards. Agenda & registration form I would be grateful if you could pass this information on to colleagues who may also be interested in this event. We hope as many of you as possible can attend and that the programme reflects the variety of work programmes and issues that is important for people in London working in and around the area of haemoglobinopathy services and meeting the care standards.
Yours sincerely, For more about sickle cell disease: http://www.sicklecellsociety.org
To patients and carers/parents of children living with sickle cell or thalassaemia INVITATION BY POPULAR DEMAND Date: Wed 4th July 2007 * There’ll be talks from leading clinicians on the latest research and treatment for sickle cell disease & thalassaemia |
| © 2005 Brent PCT |